SCHEMBL2215266

SCHEMBL2215266

CC(C)(OCc1ccc(Br)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.46
▸ RXRB P28702 1/20 0.46
▸ PPARA Q07869 4/20 0.46
▸ PPARD Q03181 2/20 0.46
▸ MAOB P27338 2/20 0.45
▸ PPARG P37231 3/20 0.45
▸ FFAR1 O14842 1/20 0.44
▸ FFAR4 Q5NUL3 1/20 0.44
▸ SLC16A3 O15427 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ SLC16A1 P53985 1/20 0.43
▸ MCTS1 Q9ULC4 1/20 0.43
▸ IDO1 P14902 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL883026 0.83 SLC16A3 (0.55) PPARAPPARDPPARGSLC16A3SLC16A1
SCHEMBL13994548 0.83 KMT2A (0.50) RXRARXRBMAOBLMNAIDO1
SCHEMBL2352150 0.82 RXRA (0.46) RXRARXRBPPARAPPARDPPARG
SCHEMBL8935661 0.82 SLC16A3 (0.46) PPARAMAOBPPARGSLC16A3SLC16A1
SCHEMBL11121410 0.81 RXRA (0.46) RXRARXRBMAOBFFAR1FFAR4
SCHEMBL31377393 0.81 NPC1 (0.53) PPARAPPARDPPARGFFAR1SLC16A3
SCHEMBL2221138 0.81 SLC16A3 (0.53) PPARGSLC16A3LMNASLC16A1MCTS1
SCHEMBL8935846 0.79 PPARA (0.50) PPARAPPARDMAOBPPARGFFAR1
SCHEMBL2218889 0.79 KMT2A (0.41) RXRARXRBMAOBFFAR1FFAR4
Clobuzarit SCHEMBL187456 0.78 SLC16A3 (0.62) PPARAPPARGSLC16A3SLC16A1MCTS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4482571-A BENZYLOXY ACIDS UNIVERSITY OF PITTSBURGH (US) 1984-11-13 — — US claimed
US-8722686-B2 Hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2014-05-13 — — US disclosed
US-20110178042-A1 Hydroxamic Acid Derivatives Useful as Antibacterial Agents PFIZER INC. (US) 2011-07-21 — — US disclosed
US-4482571-A BENZYLOXY ACIDS UNIVERSITY OF PITTSBURGH (US) 1984-11-13 — — US disclosed
US-4482571-A BENZYLOXY ACIDS UNIVERSITY OF PITTSBURGH (US) 1984-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178042-A1 Hydroxamic Acid Derivatives Useful as Antibacterial Agents HCAR1, HDAC1, H1-0 RXRA 823/4885RXRB 1017/4885PPARA 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback